Marshall Wace, LLP Neuro Sense Therapeutics Ltd. Call Options Transaction History
Marshall Wace, LLP
- $81.7 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NRSN
# of Institutions
14Shares Held
385KCall Options Held
0Put Options Held
0-
Ken Griffin Citadel Advisors LLC | Chicago, Il149KShares$188,0460.0% of portfolio
-
Morgan Stanley New York, NY50.5KShares$63,6310.0% of portfolio
-
Squarepoint Ops LLC New York, NY49.9KShares$62,9050.0% of portfolio
-
Meitav Dash Investments LTD40KShares$50,4000.0% of portfolio
-
Jane Street Group, LLC New York, NY28.7KShares$36,1480.0% of portfolio
About NeuroSense Therapeutics Ltd.
- Ticker NRSN
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,674,000
- Market Cap $14.7M